Multiparametric MRI for Characterization of Hepatocellular Carcinoma

Recruiting now

Conditions studied: Hepatocellular Carcinoma (HCC)

In brief

This prospective observational study investigates using multiparametric magnetic resonance imaging (MRI) to improve the characterization and management of therapy for hepatocellular carcinoma (HCC). The goal is to evaluate whether advanced MRI parameters can support noninvasive diagnostic assessments and personalized treatment plans for patients with HCC. The study is being conducted at a single university center in Germany and includes adult patients with confirmed or suspected HCC. Participants will undergo standardized multiparametric MRI examinations, and the imaging data will be correlated with clinical, pathological, and therapeutic outcomes. No study-specific interventions or medications will be administered.

Key facts

Study ID

NCT06999174

Run by

University Hospital Muenster

People needed

128

Starts

2025-05-01

Expected to finish

2028-05-01

Last updated by the study team

2025-07-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age ≥18 years
• Confirmed or suspected diagnosis of HCC
• Scheduled to receive TACE or SIRT as part of standard clinical care
• Eligibility for liver MRI
• Willing and able to provide written informed consent

You may not qualify if…

• Contraindications to MRI (e.g., pacemakers, ferromagnetic implants, severe claustrophobia)
• Known allergy or intolerance to gadolinium-based contrast agents
• Renal insufficiency with estimated glomerular filtration rate (eGFR) <30 mL/min/1.73m²
• Pregnancy or breastfeeding
• Inability to provide informed consent

Where it is running

• Clinic of Radiology, University of Münster — Münster, Germany (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.